Neoadjuvant chemotherapy is associated with suppression of the B cell-centered immune landscape in pancreatic ductal adenocarcinoma

Sadeleştirilmiş öğe sayfası
dc.contributor.authorRupp, Luise
dc.contributor.authorDietsche, Ina
dc.contributor.authorKiessler, Maximilian
dc.contributor.authorSommer, Ulrich
dc.contributor.authorMuckenhuber, Alexander
dc.contributor.authorSteiger, Katja
dc.contributor.authorvan Eijck, Casper W. F.
dc.contributor.authorRichter, Leonard
dc.contributor.authorIstvanffy, Rouzanna
dc.contributor.authorJaeger, Carsten
dc.contributor.authorFriess, Helmut
dc.contributor.authorvan Eijck, Casper H. J.
dc.contributor.authorDemir, Ihsan Ekin
dc.contributor.authorReyes, Carmen Mota
dc.contributor.authorSchmitz, Marc
dc.date.accessioned2025-10-16T15:13:33Z
dc.date.issued2024
dc.identifier.doi10.3389/fimmu.2024.1378190
dc.identifier.otherWOS:001202421200001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/5860
dc.publisherFRONTIERS MEDIA SA
dc.sourceFRONTIERS IN IMMUNOLOGY
dc.subjectpancreatic ductal adenocarcinoma
dc.subjecttumor immune contexture
dc.subjectB cells
dc.subjectplasma cells
dc.subjectneoadjuvant chemotherapy
dc.subjecttertiary lymphoid structures
dc.titleNeoadjuvant chemotherapy is associated with suppression of the B cell-centered immune landscape in pancreatic ductal adenocarcinoma
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS